Drugs pierce blood-brain barrier with 'delivery vector'

South Korean scientists breached the blood-brain barrier in mice with a "drug delivery vector" that could ferry cancer treatments to hard-to-treat tumors. Report

Suggested Articles

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.